Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Just a few examples

Just a few examples

posted on Sep 15, 2009 10:22AM

I guess if we were more reliant on patent licensing revenue, we might see something similar from PTSC. Thank goodness we don't need the MMP to survive.

http://ipbiz.blogspot.com/2005/11/pfizer-gets-favorable-re-exam-result.html

Pfizer gets favorable result in Lipitor Patent

http://www.azonano.com/news.asp?newsID=4458

Ciphergen Biosystems Receives Notice of Intent from U.S. Patent Office for Re-Issuance of SELDI Mass Spectrometry Patent

http://www.entrepreneur.com/PRNewswire/release/174901.html

LunarEYE Announces Successful Termination of USPTO Reexamination and Enhancement of Its 6,484,035 Patent

http://blog.taragana.com/pr/finjans-gateway-security-patent-receives-second-approval-by-us-patent-office-2800/

Finjan's Gateway Security Patent Receives Second Approval by US Patent Office

http://www.pr-inside.com/neomedia-s-barcode-lookup-patent-approved-r1066302.htm

NeoMedia's Barcode Lookup Patent ApprovedNeoMedia's Barcode Lookup Patent Approved

http://www.highbeam.com/doc/1G1-53403190.html

Article: Patent Office Reaches Favorable Decision in Re-Examinations of SONUS Patents

http://www.lumension.com/nwr_pressReleasesDetails.jsp?id=153610&metadataId=153610

U.S. Patent and Trademark Office Issues Notice of Intent to Issue Ex Parte Reexamination Certificate Relating to Lumension's Patented Patching Technology

http://www.patentdocs.org/2008/04/stemcells-paten.html

StemCells' Patents Survive Reexam -- StemCells and Neuralstem Differ on Extent of Changes

2
Sep 15, 2009 10:38AM
3
Sep 15, 2009 11:00AM
Share
New Message
Please login to post a reply